Medica welcomes new Chair and CEO
HASTINGS, UK – 4 January 2024 – Medica Group (“Medica” or “the Group”), a market-leading teleradiology provider in the UK and Ireland and provider of imaging solutions to clinical trials in the US, is delighted to announce that Tom Riall has joined as Chair and Andrew Cannon will join as CEO. These changes follow the acquisition of Medica by IK Partners (“IK”) in July 2023, which saw it successfully delist the Group from the London Stock Exchange.
Tom brings considerable experience of operating in the healthcare sector and people-centric businesses, specifically within outsourced services in supply-constrained markets. He is currently Chair of Kingsbridge Healthcare Group (the only Irish hospital group with hospitals on both sides of the Irish border) and MyDentist (Europe’s largest dental care provider). Prior to this and following several senior roles at Serco (outsourced service provider to the public sector), including CEO of the Global Services Division, Tom was CEO of MyDentist and The Priory Group (UK’s leading provider of mental healthcare services).
Andrew will join Medica in early April from Voyage Care (a provider of specialist care and support for people with learning and physical disabilities, brain injuries, autism, and complex needs), where he has been CEO since 2015 and successfully led the business through a period of transformational growth. He brings extensive senior leadership experience in healthcare services, where a focus on people and quality is paramount. Prior to his current role, he spent 10 years at Bupa, where he held a number of senior commercial leadership roles, including Managing Director of Care Services, Director of Healthcare Delivery and Head of Customer Services, after spending the earlier part of his career in finance related roles.
Pete Wilson, Partner at IK, commented: “We are delighted to welcome Tom and Andrew to Medica with their wealth of experience and impressive track records in healthcare services. The Group’s ability to attract such high-calibre individuals is testament to the strength of its service offering, the quality of its people and both Tom and Andrew’s belief in the market opportunity for Medica.
We would like to take this opportunity to thank Stuart Quin for his leadership of the Group over the last four years and wish him the very the best when he leaves his role as CEO at the end of January.”
Tom Riall, Chair of Medica, added: “I am thrilled to have joined Medica at such an important time given the role we play, in partnership with our customers, to help reduce imaging backlogs, bring down waiting times and ultimately improve clinical outcomes for patients. I have been hugely impressed with the relentless focus of our teams to deliver outstanding services to our customers.”
Andrew Cannon, incoming CEO of Medica, said: “As well as its market-leading position, one of the key attractions for me when deciding to join Medica was the focus on service quality and the highest standards of clinical governance. I look forward to working closely with Tom and the rest of the team at Medica to continue delivering collaborative and responsive telemedicine solutions that put patient outcomes at the heart of everything it does.”